H. pylori and its modulation of gastrointestinal microbiota

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|16|3|109-117

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.16, Iss.3, 2015-03, pp. : 109-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2213-2219

Bentham Science Publishers

Access to resources Recommend Favorite

Antibiotic-Resistant H. pylori Infection and Its Treatment

By  

Current Pharmaceutical Design, Vol. 6, Iss. 15, 2000-10 ,pp. : 1537-1544

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Gastrointestinal Microbiota in Colorectal Cancer

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1524-1527

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Gut Microbiota and Gastrointestinal Diseases: To Treat or Not to Treat

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4533-4534

Bentham Science Publishers

Access to resources Recommend Favorite

Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 3, 2016-02 ,pp. : 179-185

Bentham Science Publishers

Access to resources Recommend Favorite